Altered availability of PD-1/PD ligands is associated with the failure to control autoimmunity in NOD mice

Cellular Immunology

Volumn 258, Issue 2, 2009, Pages 161-171

  Yadav, Deepak ^a   Hill, Natasha ^a   Yagita, Hideo ^b   Azuma, Miyuki ^c   Sarvetnick, Nora ^a  

^a SCRIPPS RESEARCH INSTITUTE   (United States)

^b JUNTENDO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^c TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

Author keywords

Autoimmunity; B7 DC; B7 H1; Costimulation; Diabetes; PD 1

Indexed keywords

B7 ANTIGEN; CD273 ANTIGEN; CD274 ANTIGEN; CD86 ANTIGEN; CYTOKINE; LIGAND; LYMPHOCYTE ANTIGEN; PROTEIN; PROTEIN PD 1; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL TISSUE; ANTIGEN PRESENTING CELL; ARTICLE; AUTOIMMUNITY; C57BL 6 MOUSE; CONTROLLED STUDY; DENDRITIC CELL; DIABETES MELLITUS; DISEASE PREDISPOSITION; FEMALE; HELPER CELL; IMMUNOREGULATION; IMPAIRED GLUCOSE TOLERANCE; IN VIVO STUDY; LYMPH NODE; MOUSE; NONHUMAN; NONOBESE DIABETIC MOUSE; PANCREAS ISLET; PRIORITY JOURNAL; PROTEIN EXPRESSION; SUPPRESSOR CELL; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION; UPREGULATION;

AGE FACTORS; ANIMALS; ANTIGEN-PRESENTING CELLS; ANTIGENS, CD80; ANTIGENS, DIFFERENTIATION; APOPTOSIS REGULATORY PROTEINS; DIABETES MELLITUS, TYPE 1; DISEASE PROGRESSION; DISEASE SUSCEPTIBILITY; FEMALE; LIGANDS; LYMPH NODES; MEMBRANE GLYCOPROTEINS; MICE; MICE, INBRED NOD; MICE, TRANSGENIC; PANCREAS; PEPTIDES; SIGNAL TRANSDUCTION; SPLEEN; T-LYMPHOCYTES;

MUS;

EID: 67649313321     PISSN: 00088749     EISSN: 10902163     Source Type: Journal    
DOI: 10.1016/j.cellimm.2009.04.006     Document Type: Article

References (45)

1. Agata Y., Kawasaki A., Nishimura H., Ishida Y., Tsubata T., Yagita H., and Honjo T. Expression of the PD-1 antigen on the surface of stimulated mouse T and B lymphocytes. Int. Immunol. 8 (1996) 765-772
2. Nishimura H., Honjo T., and Minato N. Facilitation of beta selection and modification of positive selection in the thymus of PD-1-deficient mice. J. Exp. Med. 191 (2000) 891-898
3. Nishimura H., Agata Y., Kawasaki A., Sato M., Imamura S., Minato N., Yagita H., Nakano T., and Honjo T. Developmentally regulated expression of the PD-1 protein on the surface of double-negative (CD4-CD8-) thymocytes. Int. Immunol. 8 (1996) 773-780
4. Liang S.C., Latchman Y.E., Buhlmann J.E., Tomczak M.F., Horwitz B.H., Freeman G.J., and Sharpe A.H. Regulation of PD-1, PD-L1, and PD-L2 expression during normal and autoimmune responses. Eur. J. Immunol. 33 (2003) 2706-2716
5. Yamazaki T., Akiba H., Iwai H., Matsuda H., Aoki M., Tanno Y., Shin T., Tsuchiya H., Pardoll D.M., Okumura K., Azuma M., and Yagita H. Expression of programmed death 1 ligands by murine T cells and APC. J. Immunol. 169 (2002) 5538-5545
6. Khoury S.J., and Sayegh M.H. The roles of the new negative T cell costimulatory pathways in regulating autoimmunity. Immunity 20 (2004) 529-538
7. Okazaki T., and Honjo T. The PD-1-PD-L pathway in immunological tolerance. Trends Immunol. 27 (2006) 195-201
8. -/- mice as an efficient animal model of type I diabetes. Proc. Natl. Acad. Sci. USA 102 (2005) 11823-11828
9. Lin S.J., Peacock C.D., Bahl K., and Welsh R.M. Programmed death-1 (PD-1) defines a transient and dysfunctional oligoclonal T cell population in acute homeostatic proliferation. J. Exp. Med. 204 (2007) 2321-2333
10. King C., Ilic A., Koelsch K., and Sarvetnick N. Homeostatic expansion of T cells during immune insufficiency generates autoimmunity. Cell 117 (2004) 265-277
11. Latchman Y.E., Liang S.C., Wu Y., Chernova T., Sobel R.A., Klemm M., Kuchroo V.K., Freeman G.J., and Sharpe A.H. PD-L1-deficient mice show that PD-L1 on T cells, antigen-presenting cells, and host tissues negatively regulates T cells. Proc. Natl. Acad. Sci. USA 101 (2004) 10691-10696
12. Keir M.E., Liang S.C., Guleria I., Latchman Y.E., Qipo A., Albacker L.A., Koulmanda M., Freeman G.J., Sayegh M.H., and Sharpe A.H. Tissue expression of PD-L1 mediates peripheral T cell tolerance. J. Exp. Med. 203 (2006) 883-895
13. Latchman Y., Wood C.R., Chernova T., Chaudhary D., Borde M., Chernova I., Iwai Y., Long A.J., Brown J.A., Nunes R., Greenfield E.A., Bourque K., Boussiotis V.A., Carter L.L., Carreno B.M., Malenkovich N., Nishimura H., Okazaki T., Honjo T., Sharpe A.H., and Freeman G.J. PD-L2 is a second ligand for PD-1 and inhibits T cell activation. Nat. Immunol. 2 (2001) 261-268
14. Ansari M.J., Salama A.D., Chitnis T., Smith R.N., Yagita H., Akiba H., Yamazaki T., Azuma M., Iwai H., Khoury S.J., Auchincloss Jr. H., and Sayegh M.H. The programmed death-1 (PD-1) pathway regulates autoimmune diabetes in nonobese diabetic (NOD) mice. J. Exp. Med. 198 (2003) 63-69
15. Dong H., Zhu G., Tamada K., and Chen L. B7-H1, a third member of the B7 family, co-stimulates T-cell proliferation and interleukin-10 secretion. Nat. Med. 5 (1999) 1365-1369
16. Tseng S.Y., Otsuji M., Gorski K., Huang X., Slansky J.E., Pai S.I., Shalabi A., Shin T., Pardoll D.M., and Tsuchiya H. B7-DC, a new dendritic cell molecule with potent costimulatory properties for T cells. J. Exp. Med. 193 (2001) 839-846
17. Kanai T., Totsuka T., Uraushihara K., Makita S., Nakamura T., Koganei K., Fukushima T., Akiba H., Yagita H., Okumura K., Machida U., Iwai H., Azuma M., Chen L., and Watanabe M. Blockade of B7-H1 suppresses the development of chronic intestinal inflammation. J. Immunol. 171 (2003) 4156-4163
18. Subudhi S.K., Zhou P., Yerian L.M., Chin R.K., Lo J.C., Anders R.A., Sun Y., Chen L., Wang Y., Alegre M.L., and Fu Y.X. Local expression of B7-H1 promotes organ-specific autoimmunity and transplant rejection. J. Clin. Invest. 113 (2004) 694-700
19. Wang C.J., Chou F.C., Chu C.H., Wu J.C., Lin S.H., Chang D.M., and Sytwu H.K. Protective role of programmed death 1 ligand 1 (PD-L1) in nonobese diabetic mice: the paradox in transgenic models. Diabetes 57 (2008) 1861-1869
20. Keir M.E., Latchman Y.E., Freeman G.J., and Sharpe A.H. Programmed death-1 (PD-1): PD-ligand 1 interactions inhibit TCR-mediated positive selection of thymocytes. J. Immunol. 175 (2005) 7372-7379
21. Shin T., Kennedy G., Gorski K., Tsuchiya H., Koseki H., Azuma M., Yagita H., Chen L., Powell J., Pardoll D., and Housseau F. Cooperative B7-1/2 (CD80/CD86) and B7-DC costimulation of CD4+ T cells independent of the PD-1 receptor. J. Exp. Med. 198 (2003) 31-38
22. Wang S., Bajorath J., Flies D.B., Dong H., Honjo T., and Chen L. Molecular modeling and functional mapping of B7-H1 and B7-DC uncouple costimulatory function from PD-1 interaction. J. Exp. Med. 197 (2003) 1083-1091
23. Butte M.J., Keir M.E., Phamduy T.B., Sharpe A.H., and Freeman G.J. Programmed death-1 ligand 1 interacts specifically with the B7-1 costimulatory molecule to inhibit T cell responses. Immunity 27 (2007) 111-122
24. Keir M.E., Francisco L.M., and Sharpe A.H. PD-1 and its ligands in T-cell immunity. Curr. Opin. Immunol. 19 (2007) 309-314
25. Tsutsumi Y., Jie X., Ihara K., Nomura A., Kanemitsu S., Takada H., and Hara T. Phenotypic and genetic analyses of T-cell-mediated immunoregulation in patients with Type 1 diabetes. Diabet. Med. 23 (2006) 1145-1150
26. Krakauer M., Sorensen P.S., and Sellebjerg F. CD4(+) memory T cells with high CD26 surface expression are enriched for Th1 markers and correlate with clinical severity of multiple sclerosis. J. Neuroimmunol. 181 (2006) 157-164
27. Prokunina L., Castillejo-Lopez C., Oberg F., Gunnarsson I., Berg L., Magnusson V., Brookes A.J., Tentler D., Kristjansdottir H., Grondal G., Bolstad A.I., Svenungsson E., Lundberg I., Sturfelt G., Jonssen A., Truedsson L., Lima G., Alcocer-Varela J., Jonsson R., Gyllensten U.B., Harley J.B., Alarcon-Segovia D., Steinsson K., and Alarcon-Riquelme M.E. A regulatory polymorphism in PDCD1 is associated with susceptibility to systemic lupus erythematosus in humans. Nat. Genet. 32 (2002) 666-669
28. Tsushima F., Iwai H., Otsuki N., Abe M., Hirose S., Yamazaki T., Akiba H., Yagita H., Takahashi Y., Omura K., Okumura K., and Azuma M. Preferential contribution of B7-H1 to programmed death-1-mediated regulation of hapten-specific allergic inflammatory responses. Eur. J. Immunol. 33 (2003) 2773-2782
29. Solomon M., Flodstrom-Tullberg M., and Sarvetnick N. Differences in suppressor of cytokine signaling-1 (SOCS-1) expressing islet allograft destruction in normal BALB/c and spontaneously-diabetic NOD recipient mice. Transplantation 79 (2005) 1104-1109
30. Pipeleers D.G., In't veld P.A., Van de Winkel M., Maes E., Schuit F.C., and Gepts W. A new in vitro model for the study of pancreatic A and B cells. Endocrinology 117 (1985) 806-816
31. Yadav D., Judkowski V., Flodstrom-Tullberg M., Sterling L., Redmond W.L., Sherman L., and Sarvetnick N. B7-2 (CD86) controls the priming of autoreactive CD4 T cell response against pancreatic islets. J. Immunol. 173 (2004) 3631-3639
32. Loke P., and Allison J.P. PD-L1 and PD-L2 are differentially regulated by Th1 and Th2 cells. Proc. Natl. Acad. Sci. USA 100 (2003) 5336-5341
33. Sandner S.E., Clarkson M.R., Salama A.D., Sanchez-Fueyo A., Domenig C., Habicht A., Najafian N., Yagita H., Azuma M., Turka L.A., and Sayegh M.H. Role of the programmed death-1 pathway in regulation of alloimmune responses in vivo. J. Immunol. 174 (2005) 3408-3415
34. Bour-Jordan H., Salomon B.L., Thompson H.L., Szot G.L., Bernhard M.R., and Bluestone J.A. Costimulation controls diabetes by altering the balance of pathogenic and regulatory T cells. J. Clin. Invest. 114 (2004) 979-987
35. Yadav D., and Sarvetnick N. Immunomodulation of the anti-islet CD8 T cell response by B7-2. J. Clin. Immunol. 27 (2007) 221-226
36. Yadav D., and Sarvetnick N. B7-2 regulates survival, phenotype, and function of APCs. J. Immunol. 178 (2007) 6236-6241
37. Katz J.D., Wang B., Haskins K., Benoist C., and Mathis D. Following a diabetogenic T cell from genesis through pathogenesis. Cell 74 (1993) 1089-1100
38. Verdaguer J., Schmidt D., Amrani A., Anderson B., Averill N., and Santamaria P. Spontaneous autoimmune diabetes in monoclonal T cell nonobese diabetic mice. J. Exp. Med. 186 (1997) 1663-1676
39. Martin-Orozco N., Wang Y.H., Yagita H., and Dong C. Cutting edge: programmed death (PD) ligand-1/PD-1 interaction is required for CD8+ T cell tolerance to tissue antigens. J. Immunol. 177 (2006) 8291-8295
40. Dong H., and Chen X. Immunoregulatory role of B7-H1 in chronicity of inflammatory responses. Cell Mol. Immunol. 3 (2006) 179-187
41. Nishimura H., Nose M., Hiai H., Minato N., and Honjo T. Development of lupus-like autoimmune diseases by disruption of the PD-1 gene encoding an ITIM motif-carrying immunoreceptor. Immunity 11 (1999) 141-151
42. Nishimura H., Okazaki T., Tanaka Y., Nakatani K., Hara M., Matsumori A., Sasayama S., Mizoguchi A., Hiai H., Minato N., and Honjo T. Autoimmune dilated cardiomyopathy in PD-1 receptor-deficient mice. Science 291 (2001) 319-322
43. Guleria I., Gubbels Bupp M., Dada S., Fife B., Tang Q., Ansari M.J., Trikudanathan S., Vadivel N., Fiorina P., Yagita H., Azuma M., Atkinson M., Bluestone J.A., and Sayegh M.H. Mechanisms of PDL1-mediated regulation of autoimmune diabetes. Clin. Immunol. 125 (2007) 16-25
44. Keir M.E., Freeman G.J., and Sharpe A.H. PD-1 regulates self-reactive CD8+ T cell responses to antigen in lymph nodes and tissues. J. Immunol. 179 (2007) 5064-5070
45. Dahlen E., Hedlund G., and Dawe K. Low CD86 expression in the nonobese diabetic mouse results in the impairment of both T cell activation and CTLA-4 up-regulation. J. Immunol. 164 (2000) 2444-2456